Search Results 21-30 of 11395 for anti-TNF drugs

  1. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...

  2. A Study Of CNTO 136 (Sirukumab), A Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, In Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    ... treatment with anti-TNF-alpha agents. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  3. Postoperative Infections Clinical Trials

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  4. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of ABT-494 For The Induction Of Symptomatic And Endoscopic Remission In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Immunomodulators Or Anti-TNF Therapy - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... anti-Tumor Necrosis Factor (TNF) therapy. Participation eligibility.

  5. Inflammatory Bowel Disease (IBD) Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  6. Inflammatory Bowel Disease Treatment And Response To Therapy - Mayo Clinic

    ... anti-IL-23, anti-α4β7, or TNF-cycling among UC and CD patients with secondary loss of response or partial response to a prior anti-TNF. Participation ...

  7. A Study To Assess Disease Activity And Safety Of Subcutaneous Lutikizumab (ABT-981) In Adult Participants With Moderate To Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy And Who Are Naïve To Biologic Therapy - Mayo Clinic

    ... Anti‑TNF Therapy. Amended Protocol to Include a Lutikizumab Open-Label Sub-study in Subjects Naïve to Biologic Therapy. Participation eligibility.

  8. Infliximab (intravenous route) - Mayo Clinic

    Adalimumab; Adenovirus Vaccine Type 4, Live ... Other Interactions. Certain medicines should not ... Drugs & Supplements. Infliximab (intravenous route) ...

  9. A Study To Assess Whether Etrolizumab Is A Safe And Effective Treatment For Participants With Moderately To Severely Active Crohn's Disease (CD) - Mayo Clinic

    Anti-TNF Therapy. Inadequate primary non-response: Did not respond (as ... Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs). Prophylactic ...

  10. Rheumatoid Arthritis Clinical Trials

    ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis ...